Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

The following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

 

   

March 31, 2026

(Unaudited)

   

March 31, 2025

(Unaudited)

 
Series L Preferred Stock 1     9,566,640        
Options to purchase common stock     597,550       124,600  
Warrants to purchase common stock     57,551,105       1,769,894  
Total anti-dilutive securities     67,715,295       1,894,494  

 

1 Convertible into common stock using a conversion price of $0.454 per share, as of March 31, 2026